Avricore Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, sales was CAD 2.13 million compared to CAD 0.791139 million a year ago. Net loss was CAD 0.760799 million compared to CAD 0.573439 million a year ago. Basic loss per share from continuing operations was CAD 0.01.